Results 61 to 70 of about 23,835 (226)

Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023

Scientific Reports
Vaccine-induced immunosuppression can reactivate the varicella-zoster virus, potentially leading to the development of herpes zoster. However, the literature on this topic is inconsistent, resulting in limited clarity.
Jinyoung Jeong, Hyesu Jo, Yejun Son, Jaeyu Park, Jiyeon Oh, Sooji Lee, Yi Deun Jeong, Kyeongmin Lee, Hyeon Jin Kim, Hayeon Lee, Soeun Kim, Yesol Yim, Masoud Rahmati, Jiseung Kang, Raphael Udeh, Damiano Pizzol, Lee Smith, Jiyoung Hwang, Dong Keon Yon   +18 more
doaj   +1 more source

Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases [PDF]

, 2015
BACKGROUND: The number of individuals with autoimmune inflammatory rheumatic diseases (AIIRDs) treated with immunosuppressive drugs is increasing steadily.
Bühler, S., Eperon, G., Hatz, C., Kyburz, D., Ribi, C., Siegrist, C.A., van Gompel, F., Visser, L.G.   +7 more
core   +4 more sources

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

Acta Paediatrica, EarlyView.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson, Kari Johansen, Sören Andersson   +2 more
wiley   +1 more source

Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study

BMC Infectious Diseases, 2019
Background In Japan, freeze-dried live attenuated varicella-zoster vaccine is available for adults aged ≥50 years to prevent herpes zoster. However, limited evidence has been accumulated regarding vaccine safety for patients with underlying illnesses ...
Satoko Ohfuji, Kazuya Ito, Megumi Inoue, Motoki Ishibashi, Hiroko Kumashiro, Yoshio Hirota, Eiji Kayano, Naoshi Ota   +7 more
doaj   +1 more source

Herpes Virus Infections in Kidney Transplant Patients (HINT) – a prospective observational cohort study

BMC Infectious Diseases, 2023
Background Kidney transplant recipients receive maintenance immunosuppressive therapy to avoid allograft rejection resulting in increased risk of infections and infection-related morbidity and mortality.
Sebastian Rask Hamm, Sunil Kumar Saini, Annemette Hald, Anna V. Vaaben, Natasja Wulff Pedersen, Moises Alberto Suarez-Zdunek, Zitta Barrella Harboe, Helle Bruunsgaard, Isik Somuncu Johansen, Carsten Schade Larsen, Claus Bistrup, Henrik Birn, Søren Schwartz Sørensen, Sine Reker Hadrup, Susanne Dam Nielsen   +14 more
doaj   +1 more source

No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia [PDF]

, 2010
Little is known about reactivation of latent varicella zoster virus as herpes zoster in individuals with no underlying immunosuppression. Risk factors include age, sex, ethnicity, exogenous boosting of immunity from varicella contacts, underlying cell ...
Boccia, Mt, De Antoni, F, Gatti, A, Pica, F, Sabato, AF, Volpi, A   +5 more
core   +1 more source

Health Economic Evaluation of Varicella Vaccination Within the Swedish National Vaccination Programme for Children

Acta Paediatrica, EarlyView.
ABSTRACT Aim To assess the cost‐effectiveness of including varicella vaccination in the Swedish national vaccination programme for children together with the added impact of catch‐up vaccination of susceptible older children. Methods An epidemiological transmission model was used to assess the cost‐effectiveness of a two‐dose national varicella ...
Frida Kasteng, Gianpaolo Scalia Tomba, Annika Ersson, Ellen Wolff, Sören Andersson, Kari Johansen   +5 more
wiley   +1 more source

Newly identified properties of known pharmaceuticals and myxobacterial small molecules revealed by screening for autophagy modulators

The FEBS Journal, EarlyView.
Autophagy is a cellular degradation process involved in, for example, immune responses to pathogens and neurodegeneration. To identify modulators of autophagy, we developed a microscopy‐based screening assay and identified previously unknown autophagy‐modulating activities in known drugs and natural products from myxobacteria and fungi.
Janine Fichtner, Yan Yan Beer, H. G. Mauricio Ramm, Sabrina Mühlen, Frank Surup, Jennifer Herrmann, Toni Luise Meister, Stephanie Pfaender, Ursula Bilitewski, Mark Brönstrup, Rolf Müller, Manfred Wirth, Eeva‐Liisa Eskelinen, Ingo Schmitz   +13 more
wiley   +1 more source

Review of Varicella zoster virus : from epidemiology to prevention [PDF]

, 2008
The Varicella zoster virus is a human pathogen which causes Varicella after primary infection and herpes zoster after secondary reactivation. Both disease manifestations can occur at any age; however, Varicella is seen more commonly in children whilst ...
Pace, David
core  

Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status [PDF]

Human Vaccines & Immunotherapeutics, 2015
Options for managing herpes zoster (HZ)-related pain and complications have limited effectiveness, making HZ prevention through vaccination an important strategy. Limited data are available on HZ vaccine effectiveness against confirmed HZ and manifestations of HZ among vaccinated persons.
Mona, Marin, Barbara P, Yawn, Craig M, Hales, Peter C, Wollan, Stephanie R, Bialek, John, Zhang, Marge J, Kurland, Rafael, Harpaz   +7 more
openaire   +2 more sources